Cite
HARVARD Citation
Yousaf, A. et al. (2021). Validation of CP‐GEP (Merlin Assay) for predicting sentinel lymph node metastasis in primary cutaneous melanoma patients: A U.S. cohort study. International journal of dermatology. pp. 851-856. [Online].